Evidence map›Paper›PMID 39461777›Full record

GuidelineESMO open2024

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

J Hadoux, A Lamarca, E Grande, D Deandreis, G Kaltsas, E T Janson, B Tombal, M Pavel, J Thariat, M F van Velthuysen and 5 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in ESMO open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Diagnosing the silent: the molecular landscape of non-functional parathyroid carcinoma.Virchows Archiv : an international journal of pathology · 2025
    Review
  5. The Value of Baseline [Diagnostics (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

J HadouxDépartement d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France.
A LamarcaDepartment of Oncology, OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, University of Manchester, Manchester, UK.
E GrandeDepartment of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
D DeandreisDépartement d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France; Nuclear Medicine Service, Gustave Roussy, Villejuif, France.
G KaltsasFirst Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
E T JansonDepartment of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.
B TombalInstitut de Recherche Clinique, Cliniques Universitaires Saint-Luc (UCLouvain Saint-Luc), Woluwe-Saint-Lambert, Belgium.
M PavelDepartment of Medicine 1, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany.
J ThariatDepartment of Radiation Oncology, Baclesse Cancer Center, Caen, France.
M F van VelthuysenDepartment of Pathology, Erasmus Medical Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
P HermanDepartment of Otorhinolaryngology, Head and Neck Surgery, Hôpital Lariboisière AP-HP, Paris, France.
C DromainDepartment of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
E BaudinDépartement d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France.
A BerrutiDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnosisESMO guidelineintrathyroid carcinomamanagementparathyroid carcinomarare endocrine neoplasms

Identifiers

PMID39461777
PMCPMC11549527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.